Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

How the shape, size and location of calcified carotid plaques affect stroke risk
A new analysis provides further insight into factors affecting plaque stability and subsequent ischemic events
FDA approves expanded use of PET imaging agent
The product's updated indications include quantification and long-term monitoring of amyloid plaques on imaging.
Low dose GBCA effective, safe for pediatric imaging
Although gadopiclenol is approved for adults and children ages 2 and older, there is limited data on its use in the pediatric population.
'Powerful' new PET agent improves the diagnosis of triple-negative breast cancer
The agent “exhibits powerful tumor delineation” in challenging cases of determining cancer subtypes, and could potentially lead to more personalized, effective treatment strategies.
Emergency physicians make more mistakes when interpreting imaging of multiple organs
A new analysis details the prevalence of interpretation errors in EDs, the factors that influence them and how they affect patient care.

FDA approves use of Boston Scientific DBS system during full-body MRI scans

Boston Scientific Corporation announced that it has received FDA approval for its Vercise Gevia deep brain stimulation (DBS) system to be used during full-body MRI scans.

USPSTF updates BRCA cancer screening recommendations

The U.S. Preventative Services Task Force (USPSTF) released updated recommendations for BRCA1/2 testing, suggesting practitioners increase the use of genetic counseling and testing.

Do large cities face disparities in mammography utilization?

New research published in Radiology has found that screening mammography use is highest in coastal cities, while cities within mountain states are lagging behind.

Gadolinium-free contrast agent could improve MRI safety

A new manganese-based contrast agent could help limit the use of gadolinium-based contrast agents (GBCAs) and make MRI scans safer, according to findings published in Investigative Radiology.

New MRI contrast may be safer than gadolinium-based agents

The new agent is manganese-based (Mn-PyC3A) and produces tumor contrast enhancement similarly to that seen when using “state of the art” gadolinium-based contrast agents (GBCAs).

Skin test may prevent adverse reactions to radiocontrast material

A skin test may help clinicians prevent adverse drug reactions in patients receiving radiocontrast material, according to a new study published in the American Journal of Roentgenology.

NRC proposes updated guidance for patients receiving radioactive material

The U.S. Nuclear Regulatory Commission (NRC) is asking for comments on its proposed revision to be submitted by Aug. 26.

MRI tech company Metrasens files patent infringement case

Metrasens, a Malvern, England-based MRI technology company, has filed a new patent infringement case against Nanjing Cloud Magnet Electronic Technology Limited (Cloud Magnet).

Medical Imaging

How the shape, size and location of calcified carotid plaques affect stroke risk

FDA approves expanded use of PET imaging agent

Low dose GBCA effective, safe for pediatric imaging

'Powerful' new PET agent improves the diagnosis of triple-negative breast cancer

Emergency physicians make more mistakes when interpreting imaging of multiple organs